Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019 0 28.05.2019 03:00 Jamanetwork.com This study describes point-of-sale prices for orally administered anticancer drugs offered through Medicare Part D and out-of-pocket changes in spending as a result of decreasing coinsurance and price changes between 2010 and 2019. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
